Deficient nitric oxide signalling impairs skeletal muscle growth and performance: Involvement of mitochondrial dysregulation

Skeletal Muscle

Volumn 4, Issue 1, 2014, Pages

  De Palma, Clara ^a   Morisi, Federica ^a   Pambianco, Sarah ^a   Assi, Emma ^b   Touvier, Thierry ^a   Russo, Stefania ^b   Perrotta, Cristiana ^a   Romanello, Vanina ^c   Carnio, Silvia ^c   Cappello, Valentina ^d,e   Pellegrino, Paolo ^a   Moscheni, Claudia ^a   Bassi, Maria Teresa ^b   Sandri, Marco ^c,f   Cervia, Davide ^a,g   Clementi, Emilio ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Akt FoxO3 Mul 1 axis; Akt mTOR pathway; Autophagy; Fibre growth; Mitochondrial bioenergetics; Mitochondrial network; Muscle exercise; Muscle structure; Nitric oxide synthase and signalling; Unfolded protein response

Indexed keywords

EID: 84933042111     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/s13395-014-0022-6     Document Type: Article

References (93)

1. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357:593-615.
2. Stamler JS, Meissner G: Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001, 81:209-237.
3. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995, 82:743-752.
4. Rubinstein I, Abassi Z, Coleman R, Milman F, Winaver J, Better OS: Involvement of nitric oxide system in experimental muscle crush injury. J Clin Invest 1998, 101:1325-1333.
5. De Palma C, Clementi E: Nitric oxide in myogenesis and therapeutic muscle repair. Mol Neurobiol 2012, 46:682-692.
6. McConell GK, Rattigan S, Lee-Young RS, Wadley GD, Merry TL: Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism. Am J Physiol Endocrinol Metab 2012, 303:E301-307.
7. Eu JP, Hare JM, Hess DT, Skaf M, Sun J, Cardenas-Navina I, Sun QA, Dewhirst M, Meissner G, Stamler JS: Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A 2003, 100:15229-15234.
8. Buono R, Vantaggiato C, Pisa V, Azzoni E, Bassi MT, Brunelli S, Sciorati C, Clementi E: Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells 2012, 30:197-209.
9. Cordani N, Pisa V, Pozzi L, Sciorati C, Clementi E: Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 2014, 32:874-885.
10. Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, Froehner SC, Hoffman EP, Chamberlain JS, Bredt DS: Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 1996, 184:609-618.
11. Crosbie RH, Barresi R, Campbell KP: Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 2002, 16:1786-1791.
12. Kobayashi YM, Rader EP, Crawford RW, Iyengar NK, Thedens DR, Faulkner JA, Parikh SV, Weiss RM, Chamberlain JS, Moore SA, Campbell KP: Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008, 456:511-515.
13. Gucuyener K, Ergenekon E, Erbas D, Pinarli G, Serdaroglu A: The serum nitric oxide levels in patients with Duchenne muscular dystrophy. Brain Dev 2000, 22:181-183.
14. Wehling M, Spencer MJ, Tidball JG: A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001, 155:123-131.
15. Wehling-Henricks M, Oltmann M, Rinaldi C, Myung KH, Tidball JG: Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 2009, 18:3439-3451.
16. Brunelli S, Sciorati C, D'Antona G, Innocenzi A, Covarello D, Galvez BG, Perrotta C, Monopoli A, Sanvito F, Bottinelli R, Ongini E, Cossu G, Clementi E: Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci U S A 2007, 104:264-269.
17. Deponti D, Francois S, Baesso S, Sciorati C, Innocenzi A, Broccoli V, Muscatelli F, Meneveri R, Clementi E, Cossu G, Brunelli S: Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. J Cell Biol 2007, 179:305-319.
18. Sciorati C, Buono R, Azzoni E, Casati S, Ciuffreda P, D'Angelo G, Cattaneo D, Brunelli S, Clementi E: Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans. Br J Pharmacol 2010, 160:1550-1560.
19. D'Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E: Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. Pharmacol Res 2012, 65:472-479.
20. Cossu MV, Cattaneo D, Fucile S, Pellegrino PM, Baldelli S, Cozzi V, Capetti A, Clementi E: Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers. Drug Des Devel Ther 2014, 8:411-419.
21. Tengan CH, Rodrigues GS, Godinho RO: Nitric oxide in skeletal muscle: role on mitochondrial biogenesis and function. Int J Mol Sci 2012, 13:17160-17184.
22. Nisoli E, Falcone S, Tonello C, Cozzi V, Palomba L, Fiorani M, Pisconti A, Brunelli S, Cardile A, Francolini M, Cantoni O, Carruba MO, Moncada S, Clementi E: Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A 2004, 101:16507-16512.
23. Clementi E, Nisoli E: Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism. Comp Biochem Physiol A Mol Integr Physiol 2005, 142:102-110.
24. Cleeter MW, Cooper JM, Darleyusmar VM, Moncada S, Schapira AH: Reversible inhibition of cytochrome-C-oxidase, the terminal enzyme of the mitochondrial respiratory-chain, by nitric-oxide - implications for neurodegenerative diseases. FEBS Lett 1994, 345:50-54.
25. De Palma C, Falcone S, Pisoni S, Cipolat S, Panzeri C, Pambianco S, Pisconti A, Allevi R, Bassi MT, Cossu G, Pozzan T, Moncada S, Scorrano L, Brunelli S, Clementi E: Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ 2010, 17:1684-1696.
26. Russell AP, Foletta VC, Snow RJ, Wadley GD: Skeletal muscle mitochondria: A major player in exercise, health and disease. Biochim Biophys Acta 1840, 2014:1276-1284.
27. Wagatsuma A, Sakuma K: Mitochondria as a potential regulator of myogenesis. ScientificWorldJournal 2013, 2013:593267.
28. Eisner V, Lenaers G, Hajnoczky G: Mitochondrial fusion is frequent in skeletal muscle and supports excitation-contraction coupling. J Cell Biol 2014, 205:179-195.
29. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y, Milan G, Masiero E, Del Piccolo P, Foretz M, Scorrano L, Rudolf R, Sandri M: Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 2010, 29:1774-1785.
30. Gomes LC, Di Benedetto G, Scorrano L: During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 2011, 13:589-598.
31. Sandri M, Coletto L, Grumati P, Bonaldo P: Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J Cell Sci 2013, 126:5325-5333.
32. Grumati P, Coletto L, Sandri M, Bonaldo P: Autophagy induction rescues muscular dystrophy. Autophagy 2011, 7:426-428.
33. Grumati P, Coletto L, Sabatelli P, Cescon M, Angelin A, Bertaggia E, Blaauw B, Urciuolo A, Tiepolo T, Merlini L, Maraldi NM, Bernardi P, Sandri M, Bonaldo P: Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat Med 2010, 16:1313-1320.
34. Haynes CM, Ron D: The mitochondrial UPR - protecting organelle protein homeostasis. J Cell Sci 2010, 123:3849-3855.
35. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD: XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell 2007, 27:53-66.
36. Iwawaki T, Akai R, Kohno K, Miura M: A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat Med 2004, 10:98-102.
37. Percival JM, Anderson KN, Huang P, Adams ME, Froehner SC: Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J Clin Invest 2010, 120:816-826.
38. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, Sandri M: FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007, 6:458-471.
39. Cervia D, Garcia-Gil M, Simonetti E, Di Giuseppe G, Guella G, Bagnoli P, Dini F: Molecular mechanisms of euplotin C-induced apoptosis: involvement of mitochondrial dysfunction, oxidative stress and proteases. Apoptosis 2007, 12:1349-1363.
40. Kuznetsov AV, Veksler V, Gellerich FN, Saks V, Margreiter R, Kunz WS: Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc 2008, 3:965-976.
41. Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D: Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 2012, 7:e34890.
42. Jacobs RA, Boushel R, Wright-Paradis C, Calbet JA, Robach P, Gnaiger E, Lundby C: Mitochondrial function in human skeletal muscle following high-altitude exposure. Exp Physiol 2013, 98:245-255.
43. Perrotta C, Buldorini M, Assi E, Cazzato D, De Palma C, Clementi E, Cervia D: The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation. Am J Pathol 2014, 184:230-247.
44. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT Method. Methods 2001, 25:402-408.
45. Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Canto C, Mottis A, Jo YS, Viswanathan M, Schoonjans K, Guarente L, Auwerx J: The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013, 154:430-441.
46. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL: Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
47. De Palma C, Morisi F, Cheli S, Pambianco S, Cappello V, Vezzoli M, Rovere-Querini P, Moggio M, Ripolone M, Francolini M, Sandri M, Clementi E: Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis 2012, 3:e418.
48. Francolini M, Brunelli G, Cambianica I, Barlati S, Barbon A, La Via L, Guarneri B, Boroni F, Lanzillotta A, Baiguera C, Ettorre M, Buffelli M, Spano P, Clementi F, Pizzi M: Glutamatergic reinnervation and assembly of glutamatergic synapses in adult rat skeletal muscle occurs at cholinergic endplates. J Neuropathol Exp Neurol 2009, 68:1103-1115.
49. Bizzozero L, Cazzato D, Cervia D, Assi E, Simbari F, Pagni F, De Palma C, Monno A, Verdelli C, Querini PR, Russo V, Clementi E, Perrotta C: Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway. Cell Death Differ 2014, 21:507-520.
50. Armani C, Catalani E, Balbarini A, Bagnoli P, Cervia D: Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol 2007, 81:845-855.
51. Sciorati C, Touvier T, Buono R, Pessina P, Francois S, Perrotta C, Meneveri R, Clementi E, Brunelli S: Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting. J Cell Sci 2009, 122:1119-1125.
52. Carlson CG, Rutter J, Bledsoe C, Singh R, Hoff H, Bruemmer K, Sesti J, Gatti F, Berge J, McCarthy L: A simple protocol for assessing inter-trial and inter-examiner reliability for two noninvasive measures of limb muscle strength. J Neurosci Methods 2010, 186:226-230.
53. George Carlson C, Bruemmer K, Sesti J, Stefanski C, Curtis H, Ucran J, Lachey J, Seehra JS: Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse. Muscle Nerve 2011, 43:694-699.
54. Wu J, Ruas JL, Estall JL, Rasbach KA, Choi JH, Ye L, Bostrom P, Tyra HM, Crawford RW, Campbell KP, Rutkowski DT, Kaufman RJ, Spiegelman BM: The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1alpha/ATF6alpha complex. Cell Metab 2011, 13:160-169.
55. Sandri M: Autophagy in skeletal muscle. FEBS Lett 2010, 584:1411-1416.
56. Jovaisaite V, Mouchiroud L, Auwerx J: The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease. J Exp Biol 2014, 217:137-143.
57. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ: A mitochondrial specific stress response in mammalian cells. EMBO J 2002, 21:4411-4419.
58. Ju JS, Varadhachary AS, Miller SE, Weihl CC: Quantitation of "autophagic flux" in mature skeletal muscle. Autophagy 2010, 6:929-935.
59. Fader CM, Colombo MI: Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 2009, 16:70-78.
60. Francis SH, Busch JL, Corbin JD, Sibley D: cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010, 62:525-563.
61. De Palma C, Di Paola R, Perrotta C, Mazzon E, Cattaneo D, Trabucchi E, Cuzzocrea S, Clementi E: Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects. Pharmacol Res 2009, 60:221-228.
62. Cazzato D, Assi E, Moscheni C, Brunelli S, De Palma C, Cervia D, Perrotta C, Clementi E: Nitric oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors. Exp Cell Res 2014, 320:269-280.
63. Perrotta C, Bizzozero L, Falcone S, Rovere-Querini P, Prinetti A, Schuchman EH, Sonnino S, Manfredi AA, Clementi E: Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res 2007, 67:7559-7564.
64. Paolucci C, Rovere P, De Nadai C, Manfredi AA, Clementi E: Nitric oxide inhibits the tumor necrosis factor alpha -regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way. J Biol Chem 2000, 275:19638-19644.
65. Falcone S, Perrotta C, De Palma C, Pisconti A, Sciorati C, Capobianco A, Rovere-Querini P, Manfredi AA, Clementi E: Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J Immunol 2004, 173:4452-4463.
66. Clementi E, Sciorati C, Nistico G: Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway. Mol Pharmacol 1995, 48:1068-1077.
67. Mehrpour M, Esclatine A, Beau I, Codogno P: Overview of macroautophagy regulation in mammalian cells. Cell Res 2010, 20:748-762.
68. Lokireddy S, Wijesoma IW, Teng S, Bonala S, Gluckman PD, McFarlane C, Sharma M, Kambadur R: The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab 2012, 16:613-624.
69. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M: Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013, 280:4294-4314.
70. Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, Stantzou A, Mouisel E, Toniolo L, Ferry A, Stricker S, Goldberg AL, Dupont S, Piccolo S, Amthor H, Sandri M: BMP signaling controls muscle mass. Nat Genet 2013, 45:1309-1318.
71. Percival JM, Anderson KN, Gregorevic P, Chamberlain JS, Froehner SC: Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One 2008, 3:e3387.
72. Froehner SC, Reed SM, Anderson KN, Huang PL, Percival JM: Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. Hum Mol Genet, in press.
73. Pallafacchina G, Blaauw B, Schiaffino S: Role of satellite cells in muscle growth and maintenance of muscle mass. Nutr Metab Cardiovasc Dis 2013, 23(Suppl 1):S12-18.
74. Sandri M, Barberi L, Bijlsma AY, Blaauw B, Dyar KA, Milan G, Mammucari C, Meskers CG, Pallafacchina G, Paoli A, Pion D, Roceri M, Romanello V, Serrano AL, Toniolo L, Larsson L, Maier AB, Munoz-Canoves P, Musaro A, Pende M, Reggiani C, Rizzuto R, Schiaffino S: Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology 2013, 14:303-323.
75. Suzuki N, Motohashi N, Uezumi A, Fukada S, Yoshimura T, Itoyama Y, Aoki M, Miyagoe-Suzuki Y, Takeda S: NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 2007, 117:2468-2476.
76. Clementi E, Brown GC, Foxwell N, Moncada S: On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci U S A 1999, 96:1559-1562.
77. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
78. Gross SS, Wolin MS: Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995, 57:737-769.
79. Pellegrino MW, Nargund AM, Haynes CM: Signaling the mitochondrial unfolded protein response. Biochim Biophys Acta 1833, 2013:410-416.
80. Church JE, Gehrig SM, Chee A, Naim T, Trieu J, McConell GK, Lynch GS: Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence. Am J Physiol Regul Integr Comp Physiol 2011, 301:R1358-1366.
81. Samengo G, Avik A, Fedor B, Whittaker D, Myung KH, Wehling-Henricks M, Tidball JG: Age-related loss of nitric oxide synthase in skeletal muscle causes reductions in calpain S-nitrosylation that increase myofibril degradation and sarcopenia. Aging Cell 2012, 11:1036-1045.
82. Ito N, Ruegg UT, Kudo A, Miyagoe-Suzuki Y, Takeda S: Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy. Nat Med 2013, 19:101-106.
83. Li D, Yue Y, Lai Y, Hakim CH, Duan D: Nitrosative stress elicited by nNOSmicro delocalization inhibits muscle force in dystrophin-null mice. J Pathol 2011, 223:88-98.
84. Nguyen HX, Tidball JG: Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice. J Physiol 2003, 550:347-356.
85. Anderson JE: A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell 2000, 11:1859-1874.
86. Baum O, Vieregge M, Koch P, Gul S, Hahn S, Huber-Abel FA, Pries AR, Hoppeler H: Phenotype of capillaries in skeletal muscle of nNOS-knockout mice. Am J Physiol Regul Integr Comp Physiol 2013, 304:R1175-1182.
87. Thomas GD: Functional muscle ischemia in Duchenne and Becker muscular dystrophy. Front Physiol 2013, 4:381.
88. Bredt DS: NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 1998, 95:14592-14593.
89. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, Victor RG: Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 1998, 95:15090-15095.
90. Shibata K, Shimokawa H, Yanagihara N, Otsuji Y, Tsutsui M: Nitric oxide synthases and heart failure - lessons from genetically manipulated mice. J UOEH 2013, 35:147-158.
91. Lu XM, Zhang GX, Yu YQ, Kimura S, Nishiyama A, Matsuyoshi H, Shimizu J, Takaki M: The opposite roles of nNOS in cardiac ischemia-reperfusion-induced injury and in ischemia preconditioning-induced cardioprotection in mice. J Physiol Sci 2009, 59:253-262.
92. Chao DS, Silvagno F, Bredt DS: Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem 1998, 71:784-789.
93. Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, Chamberlain JS, Dawson VL, Dawson TM: Campbell KP: mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 1998, 7:823-829.